Skip to main content
SpringerLink
Log in

Penizillinallergie

Diagnostik unterfinanziert, zugelassene Testallergene fehlen

  • AeDA/DGAKI informieren
  • Published:
Allergo Journal Aims and scope Submit manuscript

Vor 90 Jahren — am 28. September 1928 — entdeckte Sir Alexander Flemming das Penizillin. Daher kann man den 28.09. auch als den Tag der Penizillinallergie bezeichnen. Das zur Gruppe der ß-Laktam-Antibiotika gehörende Medikament ist nicht nur das am häufigsten verwendete Antibiotikum, sondern zeichnet sich auch durch seine gute Verträglichkeit aus. Es gibt aber zwei Probleme: zum einen die zunehmende Resistenzentwicklung der Bakterien, zum anderen die häufig beobachteten allergischen Reaktionen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Li Y, Minhas JS, Blumenthal KG: Economic impact of Drug Allergy. In: D. Khan, A. Banerji (Herausg.): Drug Allergy Testing. Elsevier, St. Louis, 2018; pp.11–18

    Chapter  Google Scholar 

  2. Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (OGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). Allergo J Int 2015;24:94–105

    Article  PubMed  PubMed Central  Google Scholar 

  3. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA et al. International Consensus on drug allergy. Allergy 2014;69:420–37

    Article  CAS  PubMed  Google Scholar 

  4. Klimek L, Werfel T, Vogelberg C, Jung K. Authorised allergen products for intracutaneous testing may no longer be available in Germany: Allergy textbooks have to be re-written. Allergo J Int 2015;24:84–93

    Article  PubMed  PubMed Central  Google Scholar 

  5. Klimek L, Hoffmann HJ, Renz H, Demoly P, Werfel T, Matricardi PM, et al. Diagnostic test allergens used for in vivo diagnosis of allergic diseases are at risk: a European Perspective. Allergy 2015;70:1329–31

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Hans Merk,  Ludger Klimek &  Axel Trautmann

Authors
  1. Hans Merk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ludger Klimek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Axel Trautmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Merk, H., Klimek, L. & Trautmann, A. Diagnostik unterfinanziert, zugelassene Testallergene fehlen. Allergo J 27, 67–68 (2018). https://doi.org/10.1007/s15007-018-1737-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15007-018-1737-1

Search

Navigation